Pancreas · 2012 · 116 citations · 16 references
MedicineOncologySurgeryChemotherapyMetastasisSurgical OncologyCancer DiagnosisCancer RegistriesCancer Survival AnalysisMalignant NeoplasmsPancreatic CancerPancreatic DiseasesMetastatic Pancreatic CancerPancreatic Cancer EpidemiologyPancreatic Cancer Liver MetastasisPancreatic Cancer MortalityPancreatic MetastasesPopulation-based RegistriesTreatment Strategies
OBJECTIVES: Peritoneal carcinomatosis (PC) is an important cause of morbidity and mortality among patients with pancreatic cancer. In an era where therapeutic options for PC of multiple origins are emerging, our aim was to provide population-based data on incidence, treatment, and prognosis of PC of pancreatic origin. METHODS: All patients with a condition diagnosed as nonendocrine pancreatic cancer between 1995 and 2009 in the area of the Eindhoven Cancer Registry were included. RESULTS: In total, 2924 patients had a diagnosis of pancreatic cancer of which 265 patients (9%) presented with synchronous PC. An increasing trend could be noted in patients treated with chemotherapy in more recent years (11% in 1995-1999 and 22% in 2005-2009; P = 0.060). Median survival in patients presenting with PC was only 6 weeks (95% confidence interval, 5-7 weeks) and did not improve over time, contrasting improvements among patients with nonmetastasized disease (19-30 weeks) and patients with metastasized disease confined to the liver (8-12 weeks). CONCLUSION: Prognosis of patients with pancreatic cancer presenting with PC remains extremely poor. Treatment options are scarce and, given the magnitude of the problem, efforts should be undertaken to develop effective treatments in experimental and clinical studies.
16
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy, Françoise Desseigne, Marc Ychou et al. · New England Journal of Medicine · 2011 · 7.8K citations · Full text
Medicine, Oncology, Pharmacology +13
Howard A. Burris, Malcolm J. Moore, John Sahl Andersen et al. · Journal of Clinical Oncology · 1997 · 5.9K citations
Medicine, Oncology, Pharmacotherapy +16
Victor J. Verwaal, Sjoerd C. Bruin, Henk Boot et al. · Annals of Surgical Oncology · 2008 · 1K citations
Hedy L. Kindler, Donna Niedzwiecki, Donna Hollis et al. · Journal of Clinical Oncology · 2010 · 842 citations · Full text
Medicine, Oncology, Pharmacotherapy +11
Jordan Berlin, Paul J. Catalano, James P. Thomas et al. · Journal of Clinical Oncology · 2002 · 730 citations
Medicine, Oncology, Pharmacotherapy +12